Format

Send to

Choose Destination
Pharmacoeconomics. 2015 Dec;33(12):1245-53. doi: 10.1007/s40273-015-0316-5.

Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Author information

1
Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA, 22042, USA. zobair.younossi@inova.org.
2
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA. zobair.younossi@inova.org.
3
Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA, 22042, USA.
4
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
5
Center for Outcomes Research in Liver Diseases, Washington DC, USA.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a very common chronic liver disease worldwide, is on the rise following the trend of increasing prevalence of obesity, is the second most common indication for liver transplantation, and is an important cause for hepatocellular carcinoma. Despite the increasing recognition of NAFLD as an important chronic liver disease, little has been published on the economic and health-related quality of life (HR-QOL) impact of NAFLD. We reviewed the current literature related to the economics and HR-QOL of NAFLD and found that increased costs and decreased HR-QOL were associated with NAFLD.

PMID:
26233836
DOI:
10.1007/s40273-015-0316-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center